Prostate cancer is the most common cancer among men. Fortunately, it can be detected early by monitoring PSA levels. However, PSA tests have limited specificity for cancer, resulting in numerous unnecessary biopsies each year, which creates the need for a more precise test to help with prostate cancer detection. In this webinar, Dr. Vernon Mustoe will discuss how a simple blood test can help provide more accurate information on what an elevated PSA level might mean and the probability of finding prostate cancer on biopsy. P.A.C.E. credit is available for your participation.*
Dr. Vernon Mustoe is one of Beckman Coulter’s medical affairs managers, supporting customers with advanced clinical and technical issues. Having obtained his undergraduate and graduate degrees from New York University, he spent over 23 years in the clinical laboratory. Most recently, he was the Director of Clinical Chemistry and Assistant Director of Laboratory Services at Sisters of Charity Medical Center in Staten Island, N.Y. He has also taught Clinical Pathology at the Bayley Seton Physician Assistant School, as well as Clinical and Anatomic Pathology at the College of Staten Island Campus of the City University of New York. Dr. Mustoe has been with Beckman Coulter since 2001.